CELPHARMA
De berekende faillissementskans van CELPHARMA over 12 maanden bedraagt 2,4% (gemiddeld). Het bedrijf is actief sinds 2025 en het Belgisch Staatsblad bevat geen insolventie- of waarschuwingssignalen. Er zijn geen verwerkte jaarrekeningcijfers beschikbaar; deze conclusie steunt uitsluitend op register- en Staatsbladgegevens.
| Actief | 1 jaar |
| Vestigingen | 2 |
| Publicaties | 2 |
Statistische inschatting op basis van openbare bronnen, geen kredietadvies of vaststelling. Hoe berekenen we dit?
| NACE primair | Groothandel(46180) |
| Rechtsvorm | NV(014) |
| Oprichtingsdatum | 14-07-2025 |
| Status | Actief |
| Postcode | 1050 |
Percelen gekoppeld aan dit bedrijf via zijn adressen in de KBO (zetel, vestigingen, bijkantoren), gekruist met het kadastraal percelenplan. Dit toont waar het bedrijf actief is, geen eigendomsregister.
| Perceel (capakey) | Regio | Oppervlakte | Gebouwen | Hoogte / verd. |
|---|---|---|---|---|
| 23094D0029/00R000 | Vlaanderen | 4.801 m² | 1 · 1.270 m² | 18,4 m · 5 verd. |
| 21822R0224/00P007 | Brussel | 1.301 m² | 1 · 811 m² | 32,5 m · 9 verd. |
Eén tijdlijn van alles wat er met dit bedrijf is gebeurd, publicaties, insolventie- en levensloopgebeurtenissen, administratieve wijzigingen en neergelegde jaarrekeningen.
11-08-2025 Kapitaalverhoging van €878.981,56 tot €1.003.110,35
- €124.128,79 → €1.003.110,35
- Inbreng in natura · Apport en nature
Technische details
{
"events": [
{
"kind": "capital_increase",
"after_eur": 1003110.35,
"delta_eur": 878981.5599999999,
"before_eur": 124128.79,
"contribution_type": "natura"
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "1025.475.981",
"name_full": "CELPHARMA"
}
}22-07-2025 Oprichting van een SA
Technische details
{
"notary": {
"name": "Alain CAPRASSE",
"firm_city": null,
"firm_name": null,
"office_city": "Gr\u00E2ce-Hollogne",
"is_associated": false
},
"act_meta": {
"language": "fr",
"pub_date": "2025-07-22",
"filing_date": "2025-04-25",
"act_kind_objet": "Objet de l\u0027acte:",
"is_private_deed": false
},
"decision": {
"body": "buitengewone_algemene_vergadering",
"act_date": "2025-06-26",
"unanimous": false
},
"founders": [
{
"org": {
"kbo": "0839.631.901",
"name": "THINK BVA",
"address": "3080 Tervuren, Waalsebaan 138",
"country": "BE",
"legal_form": "SRL",
"foreign_register_name": null,
"foreign_register_number": null
},
"kind": "natural_person",
"person": {
"dob": "1984-02-20",
"name": "Bernard VAN ACKER",
"niss": null,
"address": "3080 Tervuren, Waalsebaan 138",
"nationality": "Belgium",
"place_of_birth": "Uccle, Belgium"
},
"share_class": null,
"partner_role": null,
"contribution_type": "natura",
"amount_paid_in_eur": 0.0,
"is_subscriber_only": false,
"n_shares_subscribed": 480000,
"amount_subscribed_eur": 0.0,
"is_anonymous_silent_partner": false
},
{
"org": null,
"kind": "natural_person",
"person": {
"dob": "1981-06-13",
"name": "Gabriele GAVAZZI",
"niss": null,
"address": "1200 Woluwe-Saint-Lambert, avenue de Broqueville 96/b7",
"nationality": "United States",
"place_of_birth": "Summit, New Jersey, United States"
},
"share_class": null,
"partner_role": null,
"contribution_type": "natura",
"amount_paid_in_eur": 0.0,
"is_subscriber_only": false,
"n_shares_subscribed": 155955,
"amount_subscribed_eur": 0.0,
"is_anonymous_silent_partner": false
},
{
"org": null,
"kind": "natural_person",
"person": {
"dob": null,
"name": "Marc BRAY",
"niss": null,
"address": "1180 Uccle, Avenue Jean et Pierre Carsoel 99",
"nationality": null,
"place_of_birth": null
},
"share_class": null,
"partner_role": null,
"contribution_type": "natura",
"amount_paid_in_eur": 0.0,
"is_subscriber_only": false,
"n_shares_subscribed": 214045,
"amount_subscribed_eur": 0.0,
"is_anonymous_silent_partner": false
},
{
"org": null,
"kind": "natural_person",
"person": {
"dob": null,
"name": "Florence RUESSMANN",
"niss": null,
"address": "1050 Ixelles, rue Gachard 70 boite 72",
"nationality": null,
"place_of_birth": null
},
"share_class": null,
"partner_role": null,
"contribution_type": "natura",
"amount_paid_in_eur": 0.0,
"is_subscriber_only": false,
"n_shares_subscribed": 30000,
"amount_subscribed_eur": 0.0,
"is_anonymous_silent_partner": false
},
{
"org": null,
"kind": "natural_person",
"person": {
"dob": null,
"name": "Yves BEUDIN",
"niss": null,
"address": "1050 Ixelles, rue Gachard 70 boite 72",
"nationality": null,
"place_of_birth": null
},
"share_class": null,
"partner_role": null,
"contribution_type": "natura",
"amount_paid_in_eur": 0.0,
"is_subscriber_only": false,
"n_shares_subscribed": 25000,
"amount_subscribed_eur": 0.0,
"is_anonymous_silent_partner": false
},
{
"org": {
"kbo": null,
"name": "SBAYE CONSULTING",
"address": "1050 Ixelles, avenue Louise 503/9",
"country": "BE",
"legal_form": "SRL",
"foreign_register_name": null,
"foreign_register_number": null
},
"kind": "rechtspersoon",
"person": null,
"share_class": null,
"partner_role": null,
"contribution_type": "natura",
"amount_paid_in_eur": 0.0,
"is_subscriber_only": false,
"n_shares_subscribed": 10000,
"amount_subscribed_eur": 0.0,
"is_anonymous_silent_partner": false
},
{
"org": null,
"kind": "natural_person",
"person": {
"dob": "1959-03-03",
"name": "Laurent RUESSMANN",
"niss": null,
"address": "1050 Ixelles, rue Gachard 70 boite 72",
"nationality": "United States",
"place_of_birth": "Pontiac-Michigan, United States"
},
"share_class": null,
"partner_role": null,
"contribution_type": "natura",
"amount_paid_in_eur": 0.0,
"is_subscriber_only": false,
"n_shares_subscribed": 52968,
"amount_subscribed_eur": 0.0,
"is_anonymous_silent_partner": false
},
{
"org": {
"kbo": null,
"name": "LEYS IMMO INVEST",
"address": "1050 Ixelles, avenue Louise 503/9",
"country": "BE",
"legal_form": "SRL",
"foreign_register_name": null,
"foreign_register_number": null
},
"kind": "rechtspersoon",
"person": null,
"share_class": null,
"partner_role": null,
"contribution_type": "natura",
"amount_paid_in_eur": 0.0,
"is_subscriber_only": false,
"n_shares_subscribed": 108000,
"amount_subscribed_eur": 0.0,
"is_anonymous_silent_partner": false
}
],
"voorwerp": {
"full_text": "La soci\u00E9t\u00E9 a pour objet, tant en Belgique qu\u0027\u00E0 l\u0027\u00E9tranger, pour son propre compte, pour compte de tiers ou en participation:\n\u2022 la conception, la fabrication, la vente en gros et au d\u00E9tail, l\u0027importation, l\u0027exportation et la distribution de produits cosm\u00E9tiques, de compl\u00E9ments alimentaires et de mat\u00E9riel et d\u0027articles esth\u00E9tiques ainsi que de leurs accessoires;\n\u2022 l\u0027achat, la vente, la location, la transformation et la r\u00E9novation de tous biens immeubles.\nDans le cadre de cet objet, elle peut \u00E9galement exercer toutes activit\u00E9s de relations publiques, de prospection commerciale, de consultance et de formation.\nElle peut en outre:\n\u2022 se porter caution ou fournir toutes s\u00FBret\u00E9s, personnelles ou r\u00E9elles, au profit de toute personne physique ou morale, li\u00E9e (ou associ\u00E9) ou non \u00E0 la soci\u00E9t\u00E9;\n\u2022 r\u00E9aliser toutes op\u00E9rations commerciales, industrielles, mobili\u00E8res, immobili\u00E8res ou financi\u00E8res se rapportant directement ou indirectement \u00E0 son objet social ou susceptibles d\u0027en favoriser la r\u00E9alisation ou le d\u00E9veloppement;\n\u2022 prendre la direction, la gestion ou le contr\u00F4le de soci\u00E9t\u00E9s li\u00E9es ou de filiales, notamment en qualit\u00E9 d\u0027administrateur, de g\u00E9rant ou de liquidateur, et leur fournir tous avis, services ou assistance;\n\u2022 prendre, par voie d\u0027apport, de fusion, de souscription, d\u0027acquisition, d\u0027intervention financi\u00E8re ou par tout autre moyen, des participations dans toutes soci\u00E9t\u00E9s ou entreprises, existantes ou \u00E0 constituer, en Belgique ou \u00E0 l\u0027\u00E9tranger, dont l\u0027objet est similaire, connexe ou de nature \u00E0 favoriser son propre objet social;\n\u2022 consentir des pr\u00EAts ou garantir les engagements de soci\u00E9t\u00E9s li\u00E9es ou associ\u00E9es.",
"is_lucrative": true,
"short_summary": "Conception, fabrication, vente, importation, exportation et distribution de produits cosm\u00E9tiques, compl\u00E9ments alimentaires et mat\u00E9riel esth\u00E9tique, ainsi que d\u0027immobilier."
},
"governance": {
"organ_kind": "raad_van_bestuur",
"n_directors_max": 6,
"n_directors_min": 3,
"representation_clause": "twee bestuurders gezamenlijk",
"co_signature_threshold_eur": null
},
"fiscal_year": {
"end_mm_dd": "12-31",
"start_mm_dd": "01-01",
"first_exercise_end_date": "2025-12-31",
"is_prolonged_first_exercise": false
},
"agm_schedule": {
"time": "16:00",
"month": 5,
"rule_text": "tweede vrijdag van mei"
},
"founding_event": {
"n_shares_total": 1075968,
"n_share_classes": 1,
"bank_attestation": {
"date": "2025-06-02",
"bank_name": "BNP Paribas Fortis",
"amount_eur": 0.0,
"iban_masked": "BE43 3632 6778 4001"
},
"amount_paid_in_eur": 0.0,
"incorporation_date": "2025-06-26",
"amount_subscribed_eur": 124128.79,
"art_5_8_no_payment_due": true,
"pre_incorporation_activity_from_date": "2025-01-01"
},
"subject_company": {
"kbo": "1025.475.981",
"email": null,
"region": "brussels_hoofdstedelijk_gewest",
"website": null,
"name_full": "CELPHARMA",
"legal_form": "SA",
"name_abbreviated": null,
"zetel_address_raw": "Avenue Louise 503 boite 9 \u00E0 1050 Ixelles",
"equity_account_type": "unavailable",
"_kbo_extracted_mismatch": "0625.475.981"
},
"initial_directors": [
{
"kind": "rechtspersoon",
"person": null,
"via_org": {
"kbo": "0839.631.901",
"name": "THINK BVA",
"legal_form": "SRL"
},
"role_sub": "bestuurder",
"mandate_until": {
"kind": "n_years",
"value": 6
},
"rep_person_name": "Bernard Lucien Jean VAN ACKER",
"additional_roles": [],
"bestuursverbod_checked": false,
"bestuursverbod_check_date": null,
"rep_prior_publication_ref": {
"date": "2025-04-28",
"numac_or_number": "25057779"
}
},
{
"kind": "natural_person",
"person": {
"name": "Thomas Edward Lucien Jean VAN ACKER",
"address": "1180 Uccle, Avenue Jean et Pierre Carsoel 99"
},
"via_org": null,
"role_sub": "bestuurder",
"mandate_until": {
"kind": "n_years",
"value": 6
},
"rep_person_name": null,
"additional_roles": [],
"bestuursverbod_checked": false,
"bestuursverbod_check_date": null,
"rep_prior_publication_ref": null
},
{
"kind": "natural_person",
"person": {
"name": "Laurent Antoine-Beaubien RUESSMANN",
"address": "1050 Ixelles, rue Gachard 70 boite 72"
},
"via_org": null,
"role_sub": "bestuurder",
"mandate_until": {
"kind": "n_years",
"value": 6
},
"rep_person_name": null,
"additional_roles": [],
"bestuursverbod_checked": false,
"bestuursverbod_check_date": null,
"rep_prior_publication_ref": null
},
{
"kind": "natural_person",
"person": {
"name": "Antoine Marie Pierre CARLHIAN",
"address": "1315 Incourt (Pi\u00E9trebais), Rue de l\u0027 Eglise 16B"
},
"via_org": null,
"role_sub": "bestuurder",
"mandate_until": {
"kind": "n_years",
"value": 6
},
"rep_person_name": null,
"additional_roles": [],
"bestuursverbod_checked": false,
"bestuursverbod_check_date": null,
"rep_prior_publication_ref": null
},
{
"kind": "natural_person",
"person": {
"name": "Gabriele GAVAZZI",
"address": "1200 Woluwe-Saint-Lambert, avenue de Broqueville 96/b7"
},
"via_org": null,
"role_sub": "bestuurder",
"mandate_until": {
"kind": "n_years",
"value": 6
},
"rep_person_name": null,
"additional_roles": [],
"bestuursverbod_checked": false,
"bestuursverbod_check_date": null,
"rep_prior_publication_ref": null
}
],
"co_filed_documents": [
"expedition",
"statuten",
"rapport des fondateurs",
"rapport du r\u00E9viseur d\u0027entreprises"
],
"post_incorporation_mandates": [
{
"kind": "volmacht_kbo",
"holder_org_kbo": null,
"holder_org_name": "BNP Paribas Fortis",
"with_substitution": true,
"holder_person_name": null
}
]
}Genereer een gestructureerde, feitelijke nota op basis van alle signalen in dit dossier: risico, financiële gezondheid, eigendomsstructuur, mandaten en sectorvergelijking.
| Officiële naamFR | CELPHARMA |